These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23466915)

  • 1. Electronic health record-based detection of risk factors for Clostridium difficile infection relapse.
    Hebert C; Du H; Peterson LR; Robicsek A
    Infect Control Hosp Epidemiol; 2013 Apr; 34(4):407-14. PubMed ID: 23466915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.
    McDonald EG; Milligan J; Frenette C; Lee TC
    JAMA Intern Med; 2015 May; 175(5):784-91. PubMed ID: 25730198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.
    DiDiodato G; McArthur L
    PLoS One; 2016; 11(6):e0157671. PubMed ID: 27309536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
    Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
    Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
    Faleck DM; Salmasian H; Furuya EY; Larson EL; Abrams JA; Freedberg DE
    Am J Gastroenterol; 2016 Nov; 111(11):1641-1648. PubMed ID: 27575714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
    Barletta JF; Sclar DA
    Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a risk prediction model for hospital-onset Clostridium difficile infection in patients receiving systemic antibiotics.
    Tilton CS; Johnson SW
    Am J Infect Control; 2019 Mar; 47(3):280-284. PubMed ID: 30318399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral vancomycin prophylaxis during systemic antibiotic exposure to prevent Clostridiodes difficile infection relapses.
    Caroff DA; Menchaca JT; Zhang Z; Rhee C; Calderwood MS; Kubiak DW; Yokoe DS; Klompas M
    Infect Control Hosp Epidemiol; 2019 Jun; 40(6):662-667. PubMed ID: 31030679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.
    Rodriguez S; Hernandez MB; Tarchini G; Zaleski M; Vatanchi M; Cardona L; Castro-Pavia F; Schneider A
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1856-61. PubMed ID: 24681079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a clinical prediction scale for hospital-onset Clostridium difficile infection.
    Chandra S; Thapa R; Marur S; Jani N
    J Clin Gastroenterol; 2014; 48(5):419-22. PubMed ID: 24172178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
    Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections.
    Carignan A; Poulin S; Martin P; Labbé AC; Valiquette L; Al-Bachari H; Montpetit LP; Pépin J
    Am J Gastroenterol; 2016 Dec; 111(12):1834-1840. PubMed ID: 27619835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients treated with antibiotics.
    van Werkhoven CH; van der Tempel J; Jajou R; Thijsen SF; Diepersloot RJ; Bonten MJ; Postma DF; Oosterheert JJ
    Clin Microbiol Infect; 2015 Aug; 21(8):786.e1-8. PubMed ID: 25889357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials.
    Baggs J; Yousey-Hindes K; Ashley ED; Meek J; Dumyati G; Cohen J; Wise ME; McDonald LC; Lessa FC
    Vaccine; 2015 Nov; 33(46):6241-9. PubMed ID: 26450660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.
    Skoutelis A; Pefanis A; Tsiodras S; Sipsas NV; Lelekis M; Lazanas MC; Gargalianos P; Dalekos GN; Roilides E; Samonis G; Maltezos E; Hatzigeorgiou D; Lada M; Metallidis S; Stoupis A; Chrysos G; Karnesis L; Symbardi S; Loupa CV; Giamarellou H; Kioumis I; Sambatakou H; Tsianos E; Kotsopoulou M; Georgopali A; Liakou K; Perlorentzou S; Levidiotou S; Giotsa-Toutouza M; Tsorlini-Christoforidou H; Karaiskos I; Kouppari G; Trikka-Graphakos E; Ntrivala MA; Themeli-Digalaki K; Pangalis A; Kachrimanidou M; Martsoukou M; Karapsias S; Panopoulou M; Maraki S; Orfanou A; Petinaki E; Orfanidou M; Baka V; Stylianakis A; Spiliopoulou I; Smilakou S; Zerva L; Vogiatzakis E; Belesiotou E; Gogos CA
    PLoS One; 2017; 12(8):e0182799. PubMed ID: 28813492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors that Predict Recurrent Clostridium difficile Infections in Surgical Patients.
    Messick CA; Hammel JP; Hull T
    Am Surg; 2017 Jun; 83(6):653-659. PubMed ID: 28637570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity and frequency of community-onset Clostridium difficile infection on an Australian tertiary referral hospital campus.
    Clohessy P; Merif J; Post JJ
    Int J Infect Dis; 2014 Dec; 29():152-5. PubMed ID: 25449250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electronically Available Comorbid Conditions for Risk Prediction of Healthcare-Associated Clostridium difficile Infection.
    Harris AD; Sbarra AN; Leekha S; Jackson SS; Johnson JK; Pineles L; Thom KA
    Infect Control Hosp Epidemiol; 2018 Mar; 39(3):297-301. PubMed ID: 29397800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.